TLR4 and NOD2/CARD15 genetic polymorphisms and their possible role in gastric carcinogenesis

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 513-517

  Rigoli, Luciana ^a   Di Bella, C ^a   Fedele, F ^a   Procopio, V ^a   Amorini, M ^a   Lo Giudice, G ^a   Romeo, P ^a   Pugliatti, F ^a   Finocchiaro, G ^a   Luciano R ^a   Caruso, R A ^a  

^a UNIVERSITY OF MESSINA   (Italy)

Author keywords

Gastritis; Genetic polymorphism; Histopathology; NOD2 CARD15; TLR4

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; TOLL LIKE RECEPTOR 4;

ARTICLE; CANCER RISK; CONTROLLED STUDY; FALL RISK ASSESSMENT; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; HELICOBACTER INFECTION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ANTRUM; STOMACH CARCINOGENESIS; STOMACH CARCINOMA;

ADULT; CASE-CONTROL STUDIES; FEMALE; GASTRITIS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; STOMACH NEOPLASMS; TOLL-LIKE RECEPTOR 4;

EID: 77950526750     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. IARC Working Group on the Evolution of Carcinogenic Risks to Humans: Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Evol Carcinog Risks Hum 61: 1-241, 1994.
2. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N and Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789, 2001.
3. Moss SF and Malfertheiner P: Helicobacter and gastric malignancies. Helicobacter 12(Suppl 1): 23-30, 2007.
4. Palli D, Masala G, Del Giudice G, Plebani M, Basso D, Berti D, Numans ME, Ceroti M, Peeters PH, Bueno de Mesquita HB, Buchner FL, Clavel-Chapelon F, Boutron-Ruault MC, Krogh V, Saieva C, Vineis P, Panico S, Tumino R, Nyrén O, Simán H, Berglund G, Hallmans G, Sanchez MJ, Larrãnaga N, Barricarte A, Navarro C, Quiros JR, Key T, Alle N, Bingham S, Khaw KT, Boeing H, Weikert C, Linseisen J, Nagel G, Overvad K, Thomsen RW, Tjonneland A, Olsen A, Trichoupoulou A, Trichopoulos D, Arvaniti A, Pera G, Kaaks R, Jenab M, Ferrari P, Nesi G, Carneiro F, Riboli E and Gonzalez CA: CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 120: 859-867, 2007.
5. Kamangar F, Dawsey SM, Blaser MJ, Perez-Perez GI, Pietinen P, Newschaffer CJ, Abnet CC, Ałbanes D, Virtamo J and Taylor PR: Opposing risks of gastric cardia and noncardia gastric adenocarcinomas associated with Helicobacter pylori seropositivity. J Natl Cancer Inst 98: 1445-1452, 2006.
6. Pathak SK, Basu S, Bhattacharyya A, Pathak S, Banerjee A, Basu J and Kundu M: TLR4-dependent NF-kappaB activation and mitogen- and stress-activated protein kinase 1-triggered phosphorylation events are central to Helicobacter pylori peptidyl prolyl cis-, trans-isomerase (HP0175)-mediated induction of IL-6 release from macrophages. J Immunol 177: 7950-7958, 2006.
7. Wu MS, Cheng TY, Shun CT, Lin MT, Chen LC and Lin JT: Functional polymorphisms of CD14 and toll-like receptor 4 in Taiwanese Chinese with Helicobacter pylori-related gastric malignancies. Hepatogastroenterology 53: 807-810, 2006.
8. Rosenstiel P, Hellmig S, Hampe J, Ott S, Till A, Fischbach W, Sahly H, Lucius R, Fölsch UR, Philpott D and Schreiber S: Influence of polymorphisms in the NOD1/CARD4 and NOD2/CARD15 genes on the clinical outcome of Helicobacter pylori infection. Cell Microbiol 8: 1188-1198, 2006.
9. Sambrook J, Fritsch EF and Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, E3-E4: 1989.
10. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL and Schwartz DA: TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191, 2000.
11. Mockenhaupt FP, Cramer JP, Hamann L, Stegemann MS, Eckert J, Oh NR, Otchwemah RN, Dietz E, Ehrhardt S, Schröder NW, Bienzle U and Schumann RR: Toll-like receptor (TLR) polymorphisms in African children: common TLR-4 variants predispose to severe malaria. J Commun Dis 38: 230-245, 2006.
12. Achyut BR, Ghoshal UC, Moorchung N and Mittal B: Association of toll-like receptor-4 (Asp299Gly and Thr399Ileu) gene polymorphisms with gastritis and precancerous lesions. Hum Immunol 68: 901-907, 2007.
13. Sanderson IR and Walker WA: TLRs in the Gut I: The role of TLRs/NODS in intestinal development and homeostasis. Am J Physiol Gastrointest Liver Physiol 292: G6-10, 2007.
14. Katoh M: Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer: Cancer Biol Ther 6: 832-839, 2007.
15. Snaith A and El-Omar EM: Helicobacter pylori: host genetics and disease outcomes. Expert Rev Gastroenterol Hepatol 2: 577-585, 2008.
16. Lochhead P and El-Omar EM: Gastric cancer. Br Med Bull 85: 87-100, 2008.
17. El-Omar EM, Ng MT and Hold GL: Polymorphisms in toll-like receptor genes and risk of cancer. Oncogene 27: 244-252, 2008.
18. Amieva MR and El-Omar EM: Host bacterial interactions in Helicobacter pylori infection. Gastroenterology 134: 306-323, 2008.
19. Stoicov C, Saffari R, Cai X, Hasyagar C and Houghton J: Molecular biology of gastric cancer: Helicobacter infection and gastric adenocarcinoma: bacterial and host factors responsible for altered growth signaling. Gene 341: 1-17, 2004.
20. Bonen DK and Cho JH: The genetics of inflammatory bowel disease. Gastroenterology 124: 521-536, 2003.
21. Lener MR, Oszutowska D, Castaneda J, Kurzawski G, Suchy J, Nej-Wołosiak K, Byrski T, Huzarski T, Gronwald J, Szymańska A, Szymańska-Pasternak J, Grodzki T, Serwatowski P, Borowicz G, Scott RJ and Lubiński J: Prevalence of the NOD2 3020insC mutation in aggregations of breast and lung cancer. Breast Cancer Res Treat 95: 141-145, 2006.
22. Economou M, Trikalinos TA, Loizou KT, Tsianos EV and Ioannidis JP: Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol 99: 2393-2404, 2004.
23. Ting JP and Davis BK: CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu Rev Immunol 23: 387-414, 2005.
24. Yu HG, Yu LL, Yang Y, Luo HS, Yu JP, Meier JJ, Schrader H, Bastian A, Schmidt WE and Schmitz F: Increased expression of Re1A/nuclear factor-kappa B protein correlates with colorectal tumorigenesis. Oncology 65: 37-45, 2003.